Navigation Links
Nuvasive Reports Third Quarter 2008 Financial Results
Date:10/22/2008

r the third quarter of 2008.

On a non-GAAP basis, the Company reported net income of $8.0 million, or $0.21 per share, for the third quarter of 2008. The non-GAAP earnings per share calculations exclude (i) stock based compensation of $5.4 million; (ii) a charge for in-process research and development costs of $16.7 million; (iii) a charge related to transitional support costs for the Company's ERP system of $2.6 million; (iv) a one-time leasehold charge of $4.8 million related to vacating the Company's previous headquarters; (v) amortization of acquired intangible assets of $0.9 million; and (vi) intellectual property litigation expenses of $0.6 million.

Cash, cash equivalents and short and long-term investments were $221.7 million at September 30, 2008.

Alex Lukianov, Chairman and Chief Executive Officer, said, "Our robust third quarter results reflect our growing expertise in leveraging our unique XLIF procedure to drive greater pull through of our comprehensive suite of spinal products. Our recent introductions, including those that address the thoracic and cervical spine, have further enhanced our product depth, allowing us to capture a greater market share. At NASS we unveiled NeuroVision M5, which represents a significant upgrade to our core MAS platform, further distancing our innovative lateral approach from the competition and providing our surgeon customers with an even more intuitive and user friendly system."

Mr. Lukianov concluded, "We have established a strong corporate infrastructure with the implementation of our ERP system and transition to our new headquarters, which is reinforced by the dedication of our shareowners and their commitment to making NuVasive a major force in the spine industry. Our exclusive sales force, which has grown to 300 sales professionals, has considerable momentum in the marketplace and the opportunity to gain additional market share by selling the full mix of our expanding product portfolio and
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. NuVasive to Present at Morgan Stanley Global Healthcare Unplugged Conference
2. NuVasive Completes Acquisition of Osteocel Biologics Business
3. NuVasive Announces Web Cast and Conference Call of Second Quarter 2008 Results
4. NuVasive to Present at William Blair 28th Annual Growth Stock Conference
5. NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
6. NuVasive to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference
7. NuVasive to Present at Canaccord Adams Small-Cap Orthopedics Conference
8. NuVasive Announces Webcast and Conference Call of Fourth Quarter and Full Year 2007 Results
9. NuVasive to Host Investor Reception on September 11, 2007
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Sangui Biotech International, Inc., Reports Sales Decrease, Continued Losses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 Amici Procurement Migrates to ... Amici Procurement has chosen Microsoft Cloud Solution Provider ... Office 365.      (Logo: http://photos.prnewswire.com/prnh/20121126/579634) , ... companies in the bio-tech sector with a unique procurement ... cycle to help them obtain best value. Its IT ...
(Date:7/1/2015)... 2015   Decision Resources Group finds ... Otezla are its oral administration, alternative mechanism of ... surveyed rheumatologists. Otezla was the first oral therapy ... active psoriatic arthritis in the United ... includes conventional oral treatments including disease-modifying antirheumatic drugs ...
(Date:7/1/2015)... , July 1, 2015 Isagenix International, ... has earned three Gold, three Silver, and three Bronze ... gala held in Chicago this ... the premier business awards program in the U.S. ... our company,s strength in developing leaders, cultivating talent, creating ...
(Date:7/1/2015)... July 1, 2015  UCB, a multinational biopharmaceutical ... global leader in designing, transforming, and running intelligent ... in recognition of their close collaboration in driving ... global business services (GBS) finance organization. ... clients that work together effectively to embrace the ...
Breaking Biology Technology:Biotech Procurement Company Moves to Office 365 with iomart 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Isagenix Earns Nine American Business Awards 2Isagenix Earns Nine American Business Awards 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5
... could have been done to avert the 26 tornadoes that ... systems for such storms and aftermath clean-up efforts are vastly ... south central and western parts of the state set a ... and, undoubtedly, took many people by surprise. , ,But thanks ...
... Inc. announced Monday that it has received additional ... process improvement to its ProFlu-1 assay. , ,The company ... three new accredited individuals, have provided an additional $850,000 ... instrument convertible into equity at increasing prices over a ...
... -- Gender politics aside, every biologist knows that men ... autism constitute one area where those differences come to the ... occur in men. Social play behaviors also differ greatly between ... play "rougher" than girls. , ,Early in human development, critical ...
Cached Biology Technology:Tornadoes put technology to work 2Tornadoes put technology to work 3Tornadoes put technology to work 4Prodesse gets new funding; improves flu assay 2Gender hormones may lend to social disorder therapies 2
(Date:7/2/2015)... Fingerprint Cards has received an order for its ... distributor World Peace Industrial Group (WPI), part of WPG Holdings. ... . Deliveries are planned to take place during Q3 ... manufacturers in Asia . The order value ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, ...
(Date:6/26/2015)... -- ATL Technology, LLC, a top provider of electromechanical contract ... solutions, headquartered in Springville, Utah , has ... corporation with locations in Santa Clara, ... ). This acquisition will incorporate MedConx,s manufacturing ... Technology,s existing facility in Costa Rica , ...
(Date:6/24/2015)... 2015 The biologics safety testing market is ... the market include growth of the pharmaceutical and biological ... Over the years, the number of drug approvals in ... the FDA approved 225 drug applications and Health Canada ... Europe accounted for 3,822 of the pharmaceutical ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... of a new type of chemical modification on an important ... certain muscular dystrophies and could potentially lead to new treatments ... the Jan. 1, 2010, issue of the journal Science ... After they are initially made, most proteins are ...
... of long-dead plants, animals, or humans allows a direct look ... kind on ancestral members of our own species have been ... modern-day human DNA contamination. Now, research by Svante Pbo from ... on December 31st in Current Biology a ...
... Researchers from the Biotechnology Foundation Laboratories at Thomas Jefferson ... in tobacco plant leaves, which may be the next ... was published online in Plant Biotechnology Journal . ... of Cancer Biology at Jefferson Medical College of Thomas ...
Cached Biology News:Unusual protein modification involved in muscular dystrophy, cancer 2Using modern sequencing techniques to study ancient modern humans 2
Human peripheral blood CD14+ monocytes, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Monocytes, B Cells, NK Cells and Stem Cells...
Yeast tRNA 50 l...
...
...
Biology Products: